Visar inlägg med etikett InnovatioCuris. Visa alla inlägg
Visar inlägg med etikett InnovatioCuris. Visa alla inlägg

fredag 30 november 2018

2019: Planning for the Year Ahead

Sweden & India - Partners in Health

A commitment has now been made by both the Swedish Socialdepartementet and the Indian Ministry of Health and Family Welfare to make 2019 the Year of Health - #SwedenIndiaHealth2019. As we plan for the year ahead, we welcome your input as your engagement is crucial to this partnership. The focus will be on aligning Swedish Triple Helix life science actors in delivering a structured solution to common challenges in India. Concrete deliverables along the care continuum is the ultimate objective of this collaboration. Once this proof of concept yields results - increased efficiency, decreased costs, healthier community - the Indian government has expressed interest in scaling the concept to other parts of the country. The Indian Ministry suggests Jodhpur, and its new All India Institute of Medical Sciences (AIIMS), as the test bed for this collaboration.

This, of course, does not preclude collaborations in other parts of India and many of our partners and members have ongoing projects throughout the country. We foresee increased activities with AIIMS New Delhi, Apollo Hospitals, Public Health Foundation of India, MaxCure Group, India Institute of Technology in Delhi, Mumbai, Bengaluru, Hyderabad, Kolkata, and Chennai, to name a few. But these will all be conducted with a view to ensure that Swedish stakeholders, despite having distinct objectives, will be moving in the same direction. Partnerships between Swedish actors is encouraged so that the momentum we have generated results in concrete (measurable) outputs.

Proposed timeline for 10-year celebrations in 2019

  • January - pre-feasibility study in Jodhpur to determine scope
  • April/May - heads of Indian hospitals will be invited to Sweden for a study visit and workshop
  • 21-23 May - Vitalis 2019 session to focus on AI & Innovation with an incoming health tech delegation which will visit incubators and hubs in Stockholm and Gothenburg
  • September - agency and private sector workshop in India
  • October/November - Indian Ministerial or Health Secretary visit to Stockholm along with the 11th Joint Working Group meeting

Other dates to keep in mind

  • 5 December - 2nd Private Sector Steering Committee Meeting
  • April/May - Indian elections

Calls out
Focus areas
  • Digital Health - non-communicable diseases, elderly care, AI, Health Tech
  • Anti-Microbial Resistance - infection control, knowledge transfer, nurse training, medtech
May I please request that if you have upcoming activities, you contact us so that we can provide the necessary support both in Sweden and in India? We will be coordinating closely with the Indian Embassy in Stockholm and the Swedish Embassy in New Delhi and one of the proposed ideas is to create a quarterly newsletter highlighting events within the life science sector between our two countries which could also act as a status report so do write to us!


torsdag 18 oktober 2018

#ICYMI: Be sure not to miss out next time


Incredible India. Thirteen Swedish health care representative traveled to India last week - in addition to the 17-person tech delegation arranged by SIBC to Bangalore, so Swedish presence was particularly high on the sub-continent - in order to begin preparations for increased collaborations during our Jubilee year 2019. With three separate tracks focused on regional collaborations, partnerships in order to achieve the Sustainable Development Goals, and private sector opportunities, the agenda for these Mini Delegations was incredibly packed.

The delegation trip itself would not have come about without the close collaboration between Swecare Foundation, Socialdepartementet, and the Embassy of Sweden in New Delhi as well as InnovatioCuris. The visibility and credibility of the delegation increase significantly when we work towards a common goal while planning these visits.

Program Overview - Track 1

The Swecare trip started with InnoHealth2018, organized by our Central Baltic Health Access partners InnovatioCuris and led by Target Market Coach, Sachin Gaur. The Swedish Ambassador to India, the inimitable Klas Molin, opened the two-day conference in Gurugram with a passionate plea to delegates to innovate together, across borders, towards a common goal. The conference's strength in fact lies attracting those who are willing to put in the time, resources, and skills to do exactly that and the B2B sessions are unparalleled in their focus on action points. Special attention was given to affordable and simple solutions, especially with regards to management of chronic disease.


The following week included study visits to Indraprastha Apollo HospitalAll India Institute of Medical Sciences (AIIMS) New Delhi, and Max Hospital Saket where the delegation had the honor of touring radiology, oncology, and infection control units at the leading hospitals in the country. The warm welcome we received touched the delegation and we hope to return the favor when these counterparts visit Sweden.


We also had very high-level access to two leading diagnostic brands in Delhi.
Dr Lal's National Reference Laboratory has arguably the most extensive network across India and we got to visit their state-of-the-art flagship center in Rohini. Dr Lal himself received our small delegation. This was followed up by a visit to the more specialized Mahajan Imaging where we had an intimate dialogue about premium Indian market, AI, and quality assurance.

After constructive discussions with a large team at the Public Health Foundation of India (PHFI) cutting across a vast range of subjects from nursing to eHealth, we ended the day with a roundtable among Swedish life science companies in India, hosted by the Swedish Chamber and Business Sweden, and a reception at the Ambassador's Residence

Program Overview - Track 2

Socialdepartments trip started with WHO's 2nd World Conference on Access to Medical Products - Achieving the SDGs 2030, where we met the leadership at the Indian Ministry of Health and Family Welfare during the inauguration. Niclas Jacobson, Socialdepartementet, spoke on Sweden's commitment to these issues and Pavan Aslapuram, EMPE Diagnostics, presented the case for Swedish colloborative structures.

The first day ended with a Team Sweden dinner hosted by our Ministry, where we got a chance to realign our objectives for the week and the year ahead.






    Representatives from Socialdepartementet, Embassy of Sweden - Economic Affairs, Swecare, eHälsomyndigheten, Business Sweden, and Forte traveled to Jodhpur on the second day, along with Joint Secretary Sunil Sharma, to conduct a site visit to the AIIMS Jodhpur. The group were treated to dinner by the Indian Ministry at the foot of the Jodhpur Fort. A visit was also made to two Health and Wellness Centers which Sweden plans to 'adopt' in order to test, and eventually showcase, Swedish solutions in the Indian context. We were very happy to see Elekta, Sectra, and Hemocue products already in use in Jodhpur.


    The delegation returned to Delhi to join the others at the Roundtable and Reception at the Embassy. And with this renewed energy and commitment, we entered into what was to be one of the most productive Joint Working Group meeting in this MoU's history on the morning of the last day.

    Program Overview - Track 3

    Representatives from Läkemedelverket and Folkhälsomyndigheten stayed back in Delhi in order to present at the WHO conference and meet with CDSCO and Safdarjung Hospital respectively. They rejoined the larger group for the Roundtable, Reception, and JWG meeting. The entire trip was rounded off by a Team Sweden meeting at the Embassy in order to debrief and delegate immediate action points.

    Most common issues raised
    • Nurse Training
    • Doctor Exchange
    • Clinical Decision Support (AI)
    • Early Screening
    • Elderly Care
    • AMR / Environmental Impact
    Participants

    Much of the reason for the success of this delegation trip rests with the participants - a dedicated set of smart, funny, and flexible individuals. Thank you for coming!
    • Karolinska University Hospital
    • Getinge
    • Aleris
    • DocOnline
    • eHealth Agency
    • Public Health Agency
    • Medical Products Agency
    • FORTE
    • Socialdepartmentet
    • Swecare Foundation
    Special Mention
    • Embassy of India in Sweden
    • EMPE Diagnostics
    • Gothenburg Business Region
    • AstraZeneca
    • Sweden-India Business Council
    • Swedish Chamber of Commerce in India (SCCI)
    • Business Sweden
    • Vinnova
    For those interested in India - come check-out India-Sweden Business Day


    onsdag 19 september 2018

    Collaboration across borders to new markets - CBHA Final Seminar

    The Central Baltic Health Access program has been part of our work at Swecare for a couple of years now. This interesting collaboration with Swedish Medtech and similar organizations in Finland, Estonia and Latvia to facilitate entry to new markets for our companies, has now come to an end. More information about the program can be found below, or check the label CBHA for all blog entries relating to the program.

    The program has involved 65 companies and included home market coaching, target market coaching, tailor-made market information and business missions to all four target markets: India, USA, South Korea, and Uganda. There have even been some sales - not bad considering the long lead times in life science and health care - and several partnership agreements, in addition to the MoUs between the Baltic partners and coaches and organizations in the target markets.


    The seminar began with a welcome by Malin Hollmark from Swedish Medtech and Piret Hirv, our program partner from Estonia who was also the moderator of the event. The seminar consisted of presentations from a coach for each market, as well as the sharing of experiences by one or two participating companies per market.

    Sachin Gaur from InnovatioCuris, Target Market Coach for India, led the discussions. He presented his recommendations under the title: ´The good, the bad and the ugly´ which was appreciated by the audience. With a population of 1.3 billion and a 90% out-of-pocket expenditure on health care, there is great need for products and services at low prices.

    Pavan Asalapuram presented EMPE Diagnostics' story and how their test kits can provide rapid information about drug-susceptibility in TB patients, which simplifies and assists doctors in providing the right treatment. The product has been received with great interest in the market and he will continue to work with Sachin to enter the Indian market. Pavan listed some of the advantages of the program, such as getting exposure and valuable contacts, proper guidance and access to local authorities.

    The next market discussed was USA and Nima Jokilaakso, the Swedish local coach from Swecare, presented lessons learned and recommendations for entering the market. Some conclusions were that companies must realize that competition is really fierce in the US market and that in order to succeed you need to do business the "American Way" (don't be shy), to partner with local associations in order to use their network and in-house competence, and make sure you have legal coverage "for when you get sued".


    Priit Kruus from the Estonian company Dermtest, that empowers general practitioners in fighting melanoma, expressed his struggle with being a small but growing company and the difficulties in prioritizing. Rasmus Hautala from Finnish Labrotex also shared his experience from the program. Their clearly defined goal of targeting the right key opinion leaders has enabled the company to reach their desired position.

    This was followed by an inspirational speech from Birgit Linnamäe, both based on her experience from assisting and preparing companies to enter the South Korean market, as well as her reflections on cultural differences. Interactions between two people can be interpreted in many ways. How people perceive things such as time, space, temperature, family, truth etc are some examples she lifted.

    Thomas Lööw from Swedish company Lifeclean presented their CBHA journey which has led to the shipping of one 40 feet container full of Lifeclean disinfectants to South Korea. Thomas mentioned that the program gave Lifeclean the opportunity to be part of a group, and he now realizes how important regular contact and relationships are for the process, both between company and coach, and with partners in the target market. The South Korea part of the seminar was concluded by Julie Yi, target market coach who gave her view of the program.

    The last market was Uganda, where Anna Riby from Swecare presented some defining characteristics of the Ugandan market which has a heterogeneous and less regulated structure, with stark differences between city / country, private / public, and high out-of-pocket spending. Important things to consider for market entry are to offer the relevant product for the patient segment and an adapted business model. She also urges companies to use WhatsApp as a means of communication rather than emails and to persevere - it will take time!
    Nina Nilsson from Bactiguard began her presentation by discussing September 13 - World Sepsis Day. Every day, every 3rd second someone dies of sepsis. With that said, she gave her input on how Bactiguard is looking at the Ugandan market potential. She described Bactiguard's process for market assessment and distributor selection. They focus on private hospitals since their buying power is much stronger. She confirmed that the process is slow, but they have not given up hope on landing a deal in the future, as demand for high-quality health care is increasing. 
    Continuous training for medical staff in infection control and use of the products will be necessary when there is a sale.

    The participants were divided into smaller groups for lunch in order to discuss and agree on recommendations for the CBHA team with regards to the program structure, coaching, and common challenges.

    After lunch, the group discussions were summarized and the common-thread for all four markets seem to be the advice that a company wanting to access the market has to be willing to spend time onsite – with potential partners – sending occasional emails is not enough. Companies should consider their own resources, collaboration is key, and the local coaches invaluable. Also, it is important to spend time to “teach the coach” – the target market coach needs to understand your needs, your products, and your offer. Plan regular meetings with the both target market coaches and local coaches.


    Before bidding farewell, Memoranda of Understanding with partners in the US market were signed by the partners on this side of the Atlantic. The American partners, the Commonwealths of Maryland and Pennsylvania and target market coach Bob Anthony, will sign during a ceremony which is part of the follow-up business mission to the US in a couple of weeks.

    The last activity of the program will be a follow-up mission to India, organized by Swecare with the support of InnovatioCuris, after which this segment of the program will be wrapped-up. However, we will continue developing the contacts and networks that the project has resulted in and the Baltic partners have agreed to apply for a second phase, covering new markets, for which the input from the final seminar will be invaluable. So even if this was the Final Seminar, we hope that it will only be one step in the ongoing collaboration with partners in the Baltics and in target markets, so that we can support companies in reaching those distant markets!


    CB Health Access program was initiated in 2016 between Estonian, Finnish, Latvian and Swedish organizations to support entrepreneurship in health technologies. The program has facilitated the entry of Estonian, Latvian, Swedish and Finnish health, med and bio- tech companies to distant markets – South Korea, USA, India and Uganda. CB Health Access provided the companies with an introduction of the target market, individual coaching both from the home country and from target market experts, market information, business missions, and support in identifying and contacting potential partners. The program has had a strong focus for the companies to achieve sales in the chosen market. The program is financed by the Central Baltic Interreg Program.

    fredag 27 april 2018

    One crucial factor we often take for granted

    In our 40 years, there is one lesson Swecare learned early, and which has been proven time and time again: successfully launching a Swedish healthcare company in a new market requires solid collaboration with a local partner. One with intimate knowledge of the local healthcare systems, long-term relationships with the key players within it, and a determination to do good. As a celebrity recently claimed – healthcare is complicated. Even those working in other industries, including defense, would agree that nowhere does local values, politics, culture, economic means have more impact than in healthcare. Projections of GDP growth, investment figures, risk assessments, population dividend and other macro figures are not enough to determine whether a product or service from within the Swedish healthcare and life science sector will be successful in a new market. Ours is a traditional sector by definition – nothing is as sacred as saving lives. Introducing new solutions even within our own borders is a challenge, doing so in countries which do not share our language, culture, social structure, even more so. Swecare realised early that our secret weapon is, and despite the advent of AI will remain for some time, our partners around the world - partners who have a stake in our success: who understand the way doctors work, hospitals purchase, politicians fund, and patient seek care.
    Swedish Medtech, Swecare, and InnovatioCuris
    representatives signing the MoU at Vitalis 2018 in Gothenburg

    This week marked another milestone in Swecare's work within the EU-funded Central Baltic Health Access project. While we served as 'local' coaches for the companies within this Swedish Medtech-led project, the success of the program was very much dependent on our 'target market' coaches. In March we signed a Memorandum of Understanding with Uganda Healthcare Federation strengthening our commitment to work together in order to support more companies in entering the Ugandan Market. And on Tuesday this week Swecare signed an MoU with Sachin Gaur of InnovatioCuris at Vitalis 2018, pledging:
    • exchange of information
    • promotion of opportunities
    • initial contact and consultation
    • networking services
    Sachin has proven to be an incredible partner, with InnovatioCuris providing the companies that traveled to India under CBHA with invaluable support. He is an expert on cyber security and innovations in healthcare management. Together with his CEO Dr VK Singh, they have turned InnovatioCuris into one of the few leading consultancies focussing solely in healthcare and life sciences in India. We hope that this project is once of many more collaborations to come.

    Tallinn Science Park Technopol, Uganda Healthcare Federation,
    and Swecare representatives signing the MoU with
    Swedish and Ugandan Ministries of Health as witness in Kampala
    CB Health Access program was initiated in 2016 between Estonian, Finnish, Latvian and Swedish technology organizations to support entrepreneurship in health technologies. The program facilitates the entry of Estonian, Latvian, Swedish and Finnish health tech companies to distant markets – South Korea, USA, India and Uganda. CB Health Access provides the companies with an introduction of the target market, individual coaching both from the home country and from target market experts, market information, business missions, and identifying and contacting potential partners, and business missions. The program has a strong focus for the companies to achieve sales in the chosen market. The program is financed by Central Baltic Interreg Program.

    For more information on the CB Health Access program see https://www.cbhealthaccess.eu/ and visit Swecare Blog.

    fredag 29 september 2017

    Central Baltic Health Access trip to India - Sept 2017

    Key takeaways


    1. You have to be excited to be there. If being in India does not make you happy then it will be very hard to motivate yourself and your team to invest time and money necessary to succeed in the Indian market. Two of the participants woke up at 2am to visit the Taj Mahal from Delhi (+3hrs one-way by car) before their 11am meetings with agencies and distributors. This passion speaks for itself, and the Indian counterparts are much more likely to go an extra mile (in this case quite literally) if you show that you are doing so yourself.

    2. A physical presence is extremely important. Most people will actually want to meet you first and then take it from there. If, in the Swedish manner, you try to book meeting weeks in advance with a set agenda, the response is unlikely to be overwhelming. One of our Swedish delegates was so concerned with what she saw as a lack of planning that she "almost didn't come, [...] but there were so many good meetings that were unprepared!" She booked her ticket days before this CBHA trip and was not disappointed.

    3. When your extremely talented and dedicated local coach tells you to take an Indian SIM card, listen to him. I regretted not having taken an old phone with me as many of my texts did not go through and data connectivity was patchy at best. There was no WiFi at the conference venue which made it difficult to follow-up and set-up meetings with the leads one had just met, an Indian number would have made life much easier.

    4. Use Whatsapp - one of the representatives of a government regulatory body said that he is unlikely to ever answer an email as he is constantly running between meetings and stuck in traffic (many official domains are inaccessible on the mobile). Get potential partners' mobile numbers and use them.


    About the trip


    The third installment of the Central Baltic Health Access project consisted of three days in Delhi and two days in Bengaluru over the third week in September. The sheer variety of meetings we managed to fit into these few days is nothing short of impressive. For this we have Sachin Gaur and his team at InnovatioCuris to thank. I believe I speak for all participants - six from Sweden, five from Estonia, and four from Finland - when I say that it was a productive trip. Company mission reviews have started to come in and we will book in coaching meetings over the next few weeks in order to ensure follow-up, but the general feeling, even after two days in Delhi, was that many promising connections have been made - with distributors, clinics, hospitals, start-ups, research institutes, regulatory agencies.
    We were also privileged to have hands-on support from both the Estonian and Swedish Embassies in Delhi. The Ambassadors spent a considerable amount of time with the companies, in order to understand the needs, challenges, and expectations of each representative. This type of local support is key for success in foreign markets. In fact Swecare is already in talks with the Embassy, Business Sweden, InnovatioCuris, Confederation of Indian Industry (CII), and Federation of Indian Chambers of Commerce & Industry (FICCI) to explore the option of making this type of business-focused trips a regular event. If you are interested in this form of deep engagement, do let us know!


    Participants:


    Representative name
    Organization
    Dr. Jaanus Pikani
    Documental, Estonia
    Ms. Piia Vettik-Leemet
    Tartu Biotechnology Park, Estonia
    Mr. Jan Erik Hedborg
    ApiRays, Sweden
    Mr. Priit Aigro
    Smart Do, Estonia
    Ms. Maarika Merirand
    Tehnopol, Estonia
    Dr. Pieter Spee
    Fibrotx, Estonia
    Ms. Malin Hollmark
    Swedish Medtech, Sweden
    Ms. Shampa Bari
    Swecare, Sweden
    Mr. Hakan Jideus
    Predicare, Sweden
    Mr. Pavan Asalapuram
    Empe diagnostics, Sweden
    Ms. Caroline Danielson
    RenaPharma, Sweden
    Mr. Joonas Ihalainen
    iCare, Finland
    Mr. Tero Karhi
    Turku Science Park, Finland
    Dr. Katja Heikkinen
    Turku AMK, Finland
    Ms. Marjatta Häsänen
    Turku AMK, Finland


    Food for thought


    Before signing off, I leave you with some few points I have pondering over since the trip.

    - If the diagnostic test costs more than the 'cure,' often antibiotics, wouldn't you too just take the latter?
    - How to tackle the aging challenge, which the Indian healthcare system is only now coming to see as a threat?
    - Can our products be price-competitive when there is such heavy tax imposed on imports into India? Is manufacturing there a viable option?
    - When it comes to product tests, must the companies fund the research themselves, or are there easily available funds in Sweden? The Indian research agencies have such funds for the work being done on their end but cannot finance the Swedish engagement, making the PPP project less tenable.